X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Indian markets in the negative 
(Thu, 10 Sep 01:30 pm) 
 
Indian Indices continued to trade on a negative note in the post noon trading session. Most sectoral indices are trading on a negative note with stocks from the aluminum and banking sectors leading the losses.

The BSE-Sensex is trading down by 214 points (down 0.8%) and the NSE-Nifty is trading down by 74 points (down 0.9%). The S&P BSE Midcap index and the S&P BSE Smallcap index are also trading in the red, down by 0.1% and 0.8% respectively. Gold prices, per 10 grams, are trading at Rs 26,102 levels. Silver price, per kilogram, is trading at Rs 35,444 levels. Crude oil is trading at Rs 2,947 per barrel. The rupee is trading at 66.47 to the US dollar.

Software stocks are trading on a mixed note with HCL Technologies and Info Edge leading the losses. As per a leading financial daily, Wipro has entered into a partnership with BlackLine Inc, a leader in Enhanced Finance Controls and Automation (EFCA) software. As part of this partnership, Wipro will offer BlackLine's platform of financial software solutions, encompassing Financial Close Management, Intercompany Hub, Reconciliation Management and Controls Assurance delivered as a cloud-based service, to finance and accounting organizations. Further, the company has reported that it will partner with BlackLine in projects and initiatives with the ultimate goal to deliver value to its clients and support them globally. Scrip of Wipro is presently trading down by nearly 1%.

Stocks in the pharmaceutical space are trading mixed with Wockhardt Ltd and Indoco Remedies leading the gains. As per a leading financial daily, Dr. Reddy's Laboratories has entered into a multi-country supply and licensing agreement with PanTheryx Inc., a global medical nutrition company. The agreement grants Dr. Reddy's the exclusive right to market and distribute PanTheryx's breakthrough nutritional intervention, DiaResQ, for infectious diarrhea in India and Nepal. The company is going to market this product under the 'Reliqua' brand. Stock of Dr. Reddy's Laboratories is presently trading down by 1.7% on the BSE.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Indian markets in the negative". Click here!

  
 

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE IT


Jul 27, 2017 (Close)

MARKET STATS